[Losartan]

Rev Med Univ Navarra. 1997 Jul-Sep;41(3):193-7.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Abnormalities, Drug-Induced / etiology
  • Adult
  • Aged
  • Angiotensin II / antagonists & inhibitors*
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / chemistry
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Interactions
  • Female
  • Hemodynamics / drug effects
  • Humans
  • Hypertension / drug therapy
  • Inactivation, Metabolic
  • Infant, Newborn
  • Kidney / blood supply
  • Kidney / drug effects
  • Losartan* / adverse effects
  • Losartan* / chemistry
  • Losartan* / pharmacology
  • Losartan* / therapeutic use
  • Male
  • Myocardial Contraction / drug effects
  • Natriuresis / drug effects
  • Pregnancy
  • Safety

Substances

  • Antihypertensive Agents
  • Angiotensin II
  • Losartan